The Food and Drug Administration (FDA) announced Tuesday that it has temporarily lifted a ban on sales of popular e-cigarette maker Juul.
“On July 5, 2022, the FDA administratively suspended the marketing denial order,” the agency’s tobacco division said. wrote in a tweet. “The agency has determined that there are scientific issues unique to the JUUL application that warrant further review.”
“This administrative stay temporarily suspends the marketing denial order during further review, but does not renew it,” FDA Tobacco said in its Twitter thread.
“The law requires that all electronic nicotine delivery systems or ENDS products, including those manufactured by JUUL, have FDA clearance to be legally marketed.” FDA Tobacco concluded. “The agency’s suspension and review do not constitute an authorization to market, sell, or ship JUUL products.”
The agency also said that the company can market its products in the US for now.
Two weeks earlier, the health agency prohibited the sale of Juul e-cigarettes, saying the company failed to prove that keeping its products on the market “would be appropriate for the protection of public health.
In a statement, FDA Commissioner Robert Califf said that Juul has played a significant role in the rise of vaping among young Americans.
“Today’s action is a further step forward in the FDA’s commitment to ensure that all e-cigarette products and electronic nicotine delivery systems currently marketed to consumers meet our public health standards,” Califf said in a statement. your statement.
A federal appeals court a day later temporarily blocked the FDA’s ban on Juul, granting the e-cigarette maker’s suspension request, noting that its order will not reflect its decision in the case.